Revenues from Israel’s Leviathan gas field surged 30% quarter-on-quarter to a record $843mn in Q3, as record production more than offset a slight drop in realized gas prices. NewMed Energy’s profit also rose sharply, although higher private royalties absorbed some of its gains.

NewMed, which holds 45.34% of Leviathan, reported sales revenues of $382.2mn on 17 November, up from $293.2mn in Q2 and $279mn a year earlier. Net profit rose to $162mn from $117.8mn in Q2 and $128.5mn a year earlier, gains of 38% and 26% respectively (see chart). (CONTINUED - 662 WORDS)